Fusobacterium nucleatum supresses anti-tumor immunity by activating CEACAM1

Fusobacterium nucleatum (F. nucleatum) is an oral anaerobe found to be enriched in colorectal cancer (CRC). Presence of F. nucleatum in CRC has been correlated with resistance to chemotherapy and poor prognosis. We previously demonstrated that the Fap2 outer-surface protein of F. nucleatum binds and...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oncoimmunology
Autors principals: Gur, Chamutal, Maalouf, Naseem, Shhadeh, Amjad, Berhani, Orit, Singer, Bernhard B., Bachrach, Gilad, Mandelboim, Ofer
Format: Artigo
Idioma:Inglês
Publicat: Taylor & Francis 2019
Matèries:
Brief Report
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6492956/
https://ncbi.nlm.nih.gov/pubmed/31069151
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2019.1581531
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars